Skip to main content

Advertisement

SpringerLink
Log in

Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Genetic polymorphisms of cytochrome P450 1A1 (CYP1A1) and glutathione S-transferase M1 (GSTM1) genes might contribute to the variability in individual susceptibility to lung cancer, but the reported results from individual studies are not always consistent. We therefore conducted a meta-analysis to systematically estimate the associations between polymorphisms of these two genes and risk of lung cancer. Twenty-one studies with 8,926 subjects were finally enrolled into this study. Meta-analysis was performed by RevMan 5.2. Odds ratio (OR) and its 95 % confidence interval (CI) were calculated to evaluate the susceptibility to lung cancer. Compared with the wild-type homozygous genotype, significantly elevated risk of lung cancer were associated with variant CYP1A1 MspI (m1/m2 + m2/m2 vs. m1/m1: OR = 1.27, 95 % CI = 1.12–1.43, P < 0.001) and deletion of GSTM1 (null vs. present: OR = 1.26, 95 % CI = 1.13–1.40, P < 0.001). Both the two genetic polymorphisms were independently associated with the risk of lung cancer. The pooled OR of lung cancer for population with both CYP1A1 MspI and GSTM1 mutations (MspI m1/m2 or m2/m2 and GSTM1 null) was 1.62 (95 % CI 1.27–2.07, P < 0.001) when compared with those without any of the above mutations, which is higher than single genetic polymorphism. In the stratified analysis, significantly higher risks of lung cancer associated with above genetic polymorphisms were found only in Asian population. This meta-analysis suggests that the CYP1A1 MspI and GSTM1 polymorphisms correlate with increased lung cancer susceptibility independently, and that there is an interaction between the two genes. However, the associations vary in different ethnic populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer. 2008;123:1–7.

    Article  CAS  PubMed  Google Scholar 

  3. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194–210.

    Article  CAS  PubMed  Google Scholar 

  4. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005;23:3175–85.

    Article  PubMed  Google Scholar 

  5. Zhang Q, Jin H, Wang L, et al. Lung cancer risk and genetic variants in East Asians: a meta-analysis. Tumour Biol. 2014. doi:10.1007/s13277-014-1671-0.

    Google Scholar 

  6. Shi X, Zhou S, Wang Z, et al. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2008;59:155–63.

    Article  PubMed  Google Scholar 

  7. Wang J, Deng Y, Li L, et al. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case–control study in Chinese population. Cancer Sci. 2003;94:448–52.

    Article  CAS  PubMed  Google Scholar 

  8. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res. 2000;463:247–83.

    Article  CAS  PubMed  Google Scholar 

  9. Ji YN, Wang Q, Lin XQ, et al. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects. Cytokine. 2012;59:324–34.

    Article  CAS  PubMed  Google Scholar 

  10. Zhao Y, Zeng J, Zhang Y, et al. GSTM1 polymorphism and lung cancer risk among East Asian populations: a meta-analysis. Tumour Biol. 2014. doi:10.1007/s13277-014-1832-1.

    Google Scholar 

  11. Dresler CM, Fratelli C, Babb J, et al. Gender differences in genetic susceptibility for lung cancer. Lung Cancer. 2000;30:153–60.

    Article  CAS  PubMed  Google Scholar 

  12. Sreeja L, Syamala V, Hariharan S, et al. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet. 2005;50:618–27.

    Article  CAS  PubMed  Google Scholar 

  13. Shah PP, Singh AP, Singh M, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res. 2008;639:1–10.

    Article  CAS  PubMed  Google Scholar 

  14. Le Marchand L, Sivaraman L, Pierce L, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 1998;58:4858–63.

    PubMed  Google Scholar 

  15. Lopez-Cima MF, Alvarez-Avellon SM, Pascual T, et al. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias. BMC Cancer. 2012;12:433.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Garcia-Closas M, Kelsey KT, Wiencke JK, et al. A case–control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 1997;8:544–53.

    Article  CAS  PubMed  Google Scholar 

  17. Wells GA, Shea B, O’Connell D, et al. 2013. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/pxford.htm. 19 Oct 2009

  18. Yang XR, Wacholder S, Xu Z, et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett. 2004;214:197–204.

    Article  CAS  PubMed  Google Scholar 

  19. Wojas-Krawczyk K, Krawczyk P, Chocholska S, et al. CYP1A1, GSTT1, and GSTM1 polymorphisms and lung cancer in Eastern Poland. Adv Clin Exp Med. 2009;18:461–71.

    Google Scholar 

  20. Quinones L, Lucas D, Godoy J, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 2001;174:35–44.

    Article  CAS  PubMed  Google Scholar 

  21. Li WY, Yue WT, Zhang LN, et al. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients. Lung. 2012;190:91–8.

    Article  CAS  PubMed  Google Scholar 

  22. Ng DPK, Tan KW, Zhao B, et al. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control. 2005;16:399–405.

    Article  PubMed  Google Scholar 

  23. Chang FH, EWang MJ, Qi J, et al. Genetic polymorphism of T6235C mutation in 3′ non-coding region of CYP1A1 and GSTM1 genes and lung cancer susceptibility in the Mongolian population. Acad J Xi’an Jiaotong Univ. 2009;21:225–9.

    CAS  Google Scholar 

  24. Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mut Res-Fundam Mol Mech Mutagen. 1998;400:201–13.

    Article  CAS  Google Scholar 

  25. Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;2012:736837.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Vineis P, Veglia F, Anttila S, et al. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions. Biomarkers. 2004;9:298–305.

    Article  CAS  PubMed  Google Scholar 

  27. Chen S, Xue K, Xu L, et al. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res. 2001;458:41–7.

    CAS  PubMed  Google Scholar 

  28. Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis. 1995;16:2331–6.

    Article  CAS  PubMed  Google Scholar 

  29. Stucker I, Jacquet M, de Waziers I, et al. Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population. Pharmacogenetics. 2000;10:617–27.

    Article  CAS  PubMed  Google Scholar 

  30. Cheng YW, Chen CY, Lin P, et al. DNA adduct level in lung tissue may act as a risk biomarker of lung cancer. Eur J Cancer. 2000;36:1381–8.

    Article  CAS  PubMed  Google Scholar 

  31. Raimondi S, Boffetta P, Anttila S, et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res. 2005;592:45–57.

    Article  CAS  PubMed  Google Scholar 

  32. Hung RJ, Boffetta P, Brockmoller J, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis. 2003;24:875–82.

    Article  CAS  PubMed  Google Scholar 

  33. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 2002;23:1343–50.

    Article  CAS  PubMed  Google Scholar 

  34. Alexandrie AK, Sundberg MI, Seidegard J, et al. Genetic susceptibility to lung-cancer with special emphasis on Cyp1a1 and Gstm1—a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis. 1994;15:1785–90.

    Article  CAS  PubMed  Google Scholar 

  35. Belogubova EV, Ulibina YM, Suvorova IK, et al. Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects. J Cancer Res Clin Oncol. 2006;132:327–31.

    Article  CAS  PubMed  Google Scholar 

  36. Gu YF, Zhang ZD, Zhang SC, et al. Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility. Zhonghua Yi Xue Za Zhi. 2007;87:3064–8 [in Chinese].

    CAS  PubMed  Google Scholar 

  37. Hong YS, Chang JH, Kwon OJ, et al. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med. 1998;30:192–8.

    Article  CAS  PubMed  Google Scholar 

  38. Jin Y, Xu H, Zhang C, et al. Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case–control study in China. BMC Cancer. 2010;10:422.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Nakachi K, Imai K, Hayashi S, et al. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993;53:2994–9.

    CAS  PubMed  Google Scholar 

  40. Wang BG, Chen SD, Zhou WP, et al. A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer. Zhonghua Zhong Liu Za Zhi. 2004;26:93–7 [in Chinese].

    CAS  PubMed  Google Scholar 

  41. Zhu XX, Hu CP, Gu QH. CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women. Zhonghua Jie He He Hu Xi Za Zhi. 2010;33:817–22 [in Chinese].

    PubMed  Google Scholar 

  42. Li Y, Chen J, Gao YQ. Influence of smoking and the polymorphisms of CYP1A1 and GSTM1 on the susceptibility of lung cancer. Zhonghua Shi Yong Zhen Duan Yu Zhi Liao Za Zhi. 2011;25:140–3 [in Chinese].

    CAS  Google Scholar 

  43. Xia Y, Sun QF, Shang B, et al. Polymorphisms of the cytochrome P450 and ghtathion s-transferase genes associated with lung cancer susceptibility for the residents in high radon-exposed area. Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi. 2008;28:327–32 [in Chinese].

    CAS  Google Scholar 

  44. Hu YL, Gao Y, Zhang Q. Genetic polymorphisms of CYP1A1, 2D6 and GSTM1 related with susceptibility to lung cancer. Zhong Liu. 1998;18:269–71 [in Chinese].

    Google Scholar 

  45. Zeng M, Chen SD, Xie CM, et al. Case control study on relationship between lung cancer and its susceptibility marker. Zhongguo Gong Gong Wei Sheng. 2005;21:771–4 [in Chinese].

    CAS  Google Scholar 

  46. Qu YH, Shi YB, Zhong LJ, et al. The genotypes of cytochrome P450 1A1 and GSTM1 in non-smoking female lung cancer. Zhong Liu. 1998;18:80–2 [in Chinese].

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, General Hospital of Beijing Military Command, 5 Nan Men Cang Road, Dong Si Shi Tiao Street, Beijing, 100700, China

    Wen Li & Jian Tan

  2. Department of Respiratory Medicine, The Forth Military Medical University Xi Jing Hospital, Xi’an, 710032, China

    Li-Qiang Song

Authors
  1. Wen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-Qiang Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, W., Song, LQ. & Tan, J. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis. Tumor Biol. 35, 9281–9290 (2014). https://doi.org/10.1007/s13277-014-2212-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2212-6

Keywords

Search

Navigation